中国学者近期发表的论文
1.	Structural and functional characterization of HIV-1 cell fusion inhibitor T20. Author: Zhang X1,2, Ding X1, Zhu Y1, Chong H1, Cui S1, He J2, Wang X3, He Y1,2. Journal: AIDS. 2019 Jan 27;33(1):1-11. doi: 10.1097/QAD.0000000000001979.    PubMed      DOI
2.	Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China. Author: Cui H1,2,3, Geng W1,2,3, Sun H1,2,3, Han X1,2,3, An M1,2,3, Jiang Y1,2,3, Zhang Z1,2,3, Chen Z4, Xu J1,2,3, Hu Q1,2,3, Zhao B1,2,3, Zhou B1,2,3, Shang H1,2,3. Journal: AIDS. 2019 Jan 27;33(1):13-22. doi: 10.1097/QAD.0000000000001981.    PubMed      DOI
3.	Increased influenza-specific antibody avidity in HIV-infected women compared with HIV-infected men on antiretroviral therapy. Author: Luo Z1, Ogunrinde E1, Li M1, Zhang L2, Martin L3, Zhou Z1, Hu Z1,4, Zhang T1,5, Li Z1,6, Zhang J1,7, Su B6, Zhang T6, Wu H6, Ma L8, Liao G8, Eckard AR3,9, Westerink MAJ1,3, Heath SL10, Jiang W1,3. Journal: AIDS. 2019 Jan 27;33(1):33-44. doi: 10.1097/QAD.0000000000002022.    PubMed      DOI
4.	Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice. Author: Ling L1,2, Wu T1, To KKW1, Cheung KW1, Lui KO3, Niu M1, Lam KS1, Wang CC4, Li J3, Wang H2, Yuen KY1, Chen Z1,2. Journal: AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002149. [Epub ahead of print]    PubMed      DOI
5.	Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice. Author: Ling L1,2, Wu T1, To KKW1, Cheung KW1, Lui KOL3, Niu M1, Lam KS1, Wang CC4, Li J3, Wang H2, Yuen KY1, Chen Z1,2. Journal: AIDS. 2019 Mar 15;33(4):F1-F12. doi: 10.1097/QAD.0000000000002149.    PubMed      DOI
6.	Critical amino acid residues and potential N-linked glycosylation sites contribute to CRF01_AE pathogenesis in Northeast China. Author: Li QH1,2, Shao B3,2, Li J4,2, Wang JY5, Song B6, Lin YL6, Huo QQ6, Liu SY6, Wang FX7, Liu SL1. Journal: AIDS. 2019 Mar 13. doi: 10.1097/QAD.0000000000002197. [Epub ahead of print]    PubMed      DOI
7.	Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41. Author: Xu W1,2, Pu J1,2, Su S1,2, Hua C1, Su X1, Wang Q1, Jiang S1,3, Lu L1. Journal: AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002208. [Epub ahead of print]    PubMed      DOI
8.	Clinical significance of elevated liver transaminases in HIV-infected patients. Author: Cai J1, Osikowicz M2, Sebastiani G2. Journal: AIDS. 2019 Apr 16. doi: 10.1097/QAD.0000000000002233. [Epub ahead of print]    PubMed      DOI
9.	Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy. Author: Li W, Yu F, Wang Q, Qi Q, Su S, Xie L, Lu L, Jiang S. Journal: AIDS. 2016 Mar 27;30(6):827-38. doi: 10.1097/QAD.0000000000000971.    PubMed
10.	Simplified HIV testing and treatment reduces mortality rate by over 60% in a trial in China. Author: Harper KN. Journal: AIDS. 2016 Jun 1;30(9):N11. doi: 10.1097/QAD.0000000000001057. No abstract available.     PubMed

同类著名期刊名称 h-index CiteScore PLoS Pathogens 174 6.02 JOURNAL OF VIROLOGY 271 4.02 REVIEWS IN MEDICAL VIROLOGY 84 3.65 Retrovirology 79 3.37 ANTIVIRAL RESEARCH 108 4.19 JOURNAL OF VIRAL HEPATITIS 93 3.39 JOURNAL OF GENERAL VIROLOGY 152 2.78 Influenza and Other Respiratory Viruses 46 3.20 INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 82 2.94 VIRUS RESEARCH 104 2.57

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 282228 CANCER RESEARCH 163270 International Journal of Nanomedicine 161658 Molecular Medicine Reports 161409 CANCER LETTERS 156729 JOURNAL OF ETHNOPHARMACOLOGY 138539 BIOMEDICINE & PHARMACOTHERAPY 136292 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133150 Theranostics 132283 International Journal of Environmental Research and Public Health 130847